Literature DB >> 27365378

Expression of microRNAs of C19MC in Different Histological Types of Testicular Germ Cell Tumour.

Inga Flor1, Meike Spiekermann2, Thomas Löning3, Klaus-Peter Dieckmann4, Gazanfer Belge2, Jörn Bullerdiek5.   

Abstract

BACKGROUND: Testicular germ cell tumours (TGCTs) are the most common tumours in men aged from 20 to 40 years, with a steadily increasing incidence. This study aimed to characterize the expression of the miRNA cluster C19MC in TGCT and to evaluate the suitability of a C19MC miRNA as a serum biomarker.
MATERIALS AND METHODS: By quantitative reverse transcription PCR, we measured the expression of miR-517a-3p, miR-519a-3p, and miR-519c 3p in tissue samples of 25 TGCTs and the level of miR-517a-3p in serum samples obtained pre- and postoperatively from the same patients.
RESULTS: We detected a significantly higher expression of C19MC miRNAs in non-seminomas than in seminomas and in clinical stages 2 and 3 than in stage 1 in both tissue and serum samples.
CONCLUSION: miRNAs of C19MC are overexpressed in more aggressive types of TGCT, suggesting they contribute to malignancy. Furthermore, they might serve as serum biomarkers for these types of TGCT. Copyright
© 2016, International Institute of Anticancer Research (Dr. John G. Delinasios), All rights reserved.

Entities:  

Keywords:  C19MC; TGCT; biomarker; miRNA; serum

Mesh:

Substances:

Year:  2016        PMID: 27365378

Source DB:  PubMed          Journal:  Cancer Genomics Proteomics        ISSN: 1109-6535            Impact factor:   4.069


  17 in total

1.  MicroRNAs in Differentiation of Embryoid Bodies and the Teratoma Subtype of Testicular Cancer.

Authors:  Mette Pernille Myklebust; Anne Mette Søviknes; Ole Johan Halvorsen; Anna Thor; Olav Dahl; Helge Ræder
Journal:  Cancer Genomics Proteomics       Date:  2022 Mar-Apr       Impact factor: 4.069

2.  MicroRNA-profiling of miR-371~373- and miR-302/367-clusters in serum and cerebrospinal fluid identify patients with intracranial germ cell tumors.

Authors:  Stefan Schönberger; Mahsa Mir Mohseni; Jörg Ellinger; Giao Vu Quynh Tran; Martina Becker; Alexander Claviez; Carl-Friedrich Classen; Barbara Hermes; Pablo Hernáiz Driever; Norbert Jorch; Melchior Lauten; Marcus Mehlitz; Niklas Schäfer; Johanna Scheer-Preiss; Dominik T Schneider; Anja Troeger; Gabriele Calaminus; Dagmar Dilloo
Journal:  J Cancer Res Clin Oncol       Date:  2022-02-16       Impact factor: 4.553

Review 3.  Examples of Inverse Comorbidity between Cancer and Neurodegenerative Diseases: A Possible Role for Noncoding RNA.

Authors:  Michele Salemi; Maria Paola Mogavero; Giuseppe Lanza; Laura M Mongioì; Aldo E Calogero; Raffaele Ferri
Journal:  Cells       Date:  2022-06-15       Impact factor: 7.666

Review 4.  Epigenetic Alterations in Parathyroid Cancers.

Authors:  Chiara Verdelli; Sabrina Corbetta
Journal:  Int J Mol Sci       Date:  2017-02-01       Impact factor: 5.923

5.  The genomic landscape of undifferentiated embryonal sarcoma of the liver is typified by C19MC structural rearrangement and overexpression combined with TP53 mutation or loss.

Authors:  Bhuvana A Setty; Goodwin G Jinesh; Michael Arnold; Fredrik Pettersson; Chia-Ho Cheng; Ling Cen; Sean J Yoder; Jamie K Teer; Elsa R Flores; Damon R Reed; Andrew S Brohl
Journal:  PLoS Genet       Date:  2020-04-20       Impact factor: 5.917

6.  The MicroRNA-371 Family as Plasma Biomarkers for Monitoring Undifferentiated and Potentially Malignant Human Pluripotent Stem Cells in Teratoma Assays.

Authors:  Daniela C F Salvatori; Lambert C J Dorssers; Ad J M Gillis; Gemma Perretta; Ton van Agthoven; Maria Gomes Fernandes; Hans Stoop; Jan-Bas Prins; J Wolter Oosterhuis; Christine Mummery; Leendert H J Looijenga
Journal:  Stem Cell Reports       Date:  2018-11-29       Impact factor: 7.765

7.  Emerging Prognostic Biomarkers in Testicular Germ Cell Tumors: Looking Beyond Established Practice.

Authors:  Michal Chovanec; Costantine Albany; Michal Mego; Rodolfo Montironi; Alessia Cimadamore; Liang Cheng
Journal:  Front Oncol       Date:  2018-11-28       Impact factor: 6.244

8.  Shared and unique genomic structural variants of different histological components within testicular germ cell tumours identified with mate pair sequencing.

Authors:  Alan H Bryce; Jan B Egan; James B Smadbeck; Sarah H Johnson; Stephen J Murphy; Faye R Harris; Geoffrey C Halling; Simone B S P Terra; John Cheville; Lance Pagliaro; Brad Leibovich; Brian A Costello; George Vasmatzis
Journal:  Sci Rep       Date:  2019-03-05       Impact factor: 4.379

9.  Regulation of MYO18B mRNA by a network of C19MC miRNA-520G, IFN-γ, CEBPB, p53 and bFGF in hepatocellular carcinoma.

Authors:  Goodwin G Jinesh; Marco Napoli; Hayley D Ackerman; Payal M Raulji; Nicole Montey; Elsa R Flores; Andrew S Brohl
Journal:  Sci Rep       Date:  2020-07-23       Impact factor: 4.996

10.  Chromosome 19 miRNA cluster and CEBPB expression specifically mark and potentially drive triple negative breast cancers.

Authors:  Goodwin G Jinesh; Elsa R Flores; Andrew S Brohl
Journal:  PLoS One       Date:  2018-10-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.